中汽協:首四月理想、小鵬及蔚來等新造車企累計銷量增逾87%
中國汽車工業協會發布最新數據顯示,今年首四個月,汽車銷量排名前十間企業集團銷量合計659.4萬輛,按年下降12.4%,佔汽車銷售總量的85.7%,低於上年同期0.3個百分點。
期內,理想汽車(02015.HK)(LI.US)、小鵬汽車(09868.HK)(XPEV.US)及蔚來(09866.HK)(NIO.US)等新造車企業累計銷量38.4萬輛,按年增長87.1%,佔汽車銷售總量的5%,佔比增長2.6個百分點。(ta/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.